斑块状银屑病-话题@MedSci

#斑块状银屑病#

28篇内容 | 1052人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2106354, encodeId=5bde21063549c, content=<a href='/topic/show?id=bd6610508362' target=_blank style='color:#2F92EE;'>#米利珠单抗#</a>可有效治疗中重度<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>成年患者, objectTitle=Br J Dermatol：米利珠单抗可有效治疗中重度斑块状银屑病成年患者, objectType=article, longId=751685, objectId=e6a5e51685c5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221120/1669013769935_4754896.jpeg, objectUrl=/article/show_article.do?id=e6a5e51685c5, replyNumber=0, likeNumber=38, createdTime=2022-12-16, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e6a5e51685c5, moduleTitle=Br J Dermatol：米利珠单抗可有效治疗中重度斑块状银屑病成年患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6a5e51685c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449613, encodeId=05091449613da, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=J Eur Acad Dermatol Venereol：Brodalumab治疗中重度斑块状银屑病的长期疗效和安全性 , objectType=article, longId=736658, objectId=f14be366588f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f14be366588f, replyNumber=0, likeNumber=43, createdTime=2022-08-24, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f14be366588f, moduleTitle=J Eur Acad Dermatol Venereol：Brodalumab治疗中重度斑块状银屑病的长期疗效和安全性 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f14be366588f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449611, encodeId=6fe8144961144, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=J Cosmet Dermatol：点阵二氧化碳激光辅助外用环孢素乳膏VS.外用氯倍他索乳膏治疗斑块状银屑病的疗效, objectType=article, longId=736640, objectId=700de3664064, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=700de3664064, replyNumber=0, likeNumber=66, createdTime=2022-08-24, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=700de3664064, moduleTitle=J Cosmet Dermatol：点阵二氧化碳激光辅助外用环孢素乳膏VS.外用氯倍他索乳膏治疗斑块状银屑病的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=700de3664064)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449612, encodeId=df1c144961223, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=Dermaliq Therapeutics宣布在评估DLQ02治疗斑块状银屑病的1b/2期试验中向首例患者给药, objectType=article, longId=736627, objectId=8550e36627cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8550e36627cf, replyNumber=0, likeNumber=44, createdTime=2022-08-24, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8550e36627cf, moduleTitle=Dermaliq Therapeutics宣布在评估DLQ02治疗斑块状银屑病的1b/2期试验中向首例患者给药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8550e36627cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449610, encodeId=cefa1449610d2, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=Dermatol Ther：阿普斯特单药治疗是中重度斑块状银屑病的有效治疗方案, objectType=article, longId=733991, objectId=cffee33991ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cffee33991ac, replyNumber=0, likeNumber=54, createdTime=2022-08-01, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cffee33991ac, moduleTitle=Dermatol Ther：阿普斯特单药治疗是中重度斑块状银屑病的有效治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cffee33991ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449609, encodeId=7885144960944, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=Br J Dermatol：在体重≥90 kg的中重度斑块状银屑病患者中Secukinumab 的疗效如何？, objectType=article, longId=732994, objectId=5689e3299402, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5689e3299402, replyNumber=0, likeNumber=0, createdTime=2022-07-23, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5689e3299402, moduleTitle=Br J Dermatol：在体重≥90 kg的中重度斑块状银屑病患者中Secukinumab 的疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5689e3299402)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449608, encodeId=804c144960801, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=两年研究数据证实：deucravacitinib治疗中重度斑块状银屑病兼具持久的疗效与一致的安全性, objectType=article, longId=726751, objectId=4e3ee26751c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e3ee26751c7, replyNumber=0, likeNumber=51, createdTime=2022-05-14, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e3ee26751c7, moduleTitle=两年研究数据证实：deucravacitinib治疗中重度斑块状银屑病兼具持久的疗效与一致的安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e3ee26751c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449607, encodeId=11cf144960ef2, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=JEADV：新型固定剂量钙泊三醇和二丙酸倍他米松乳膏可有效且安全的治疗斑块状银屑病, objectType=article, longId=723504, objectId=63ace23504bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=63ace23504bf, replyNumber=0, likeNumber=58, createdTime=2022-04-06, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=63ace23504bf, moduleTitle=JEADV：新型固定剂量钙泊三醇和二丙酸倍他米松乳膏可有效且安全的治疗斑块状银屑病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63ace23504bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449606, encodeId=754f144960670, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=J Dermatolog Treat：ixekizumab治疗严重斑块状银屑病患者的疗效和安全性, objectType=article, longId=299288, objectId=c2b8299288cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2b8299288cb, replyNumber=0, likeNumber=55, createdTime=2022-02-22, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2b8299288cb, moduleTitle=J Dermatolog Treat：ixekizumab治疗严重斑块状银屑病患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2b8299288cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449605, encodeId=50ef1449605fd, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=BioDrugs：AVT02 VS. 原研药阿达木单抗在中重度慢性斑块状银屑病患者中的疗效、安全性和免疫原性, objectType=article, longId=293607, objectId=125629360edc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=125629360edc, replyNumber=0, likeNumber=44, createdTime=2022-01-09, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=125629360edc, moduleTitle=BioDrugs：AVT02 VS. 原研药阿达木单抗在中重度慢性斑块状银屑病患者中的疗效、安全性和免疫原性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=125629360edc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449604, encodeId=5789144960470, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=Br J Dermatol：ixekizumab与guselkumab治疗中重度斑块状银屑病的疗效和安全性, objectType=article, longId=292150, objectId=0b012921503e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b012921503e, replyNumber=0, likeNumber=0, createdTime=2021-12-19, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b012921503e, moduleTitle=Br J Dermatol：ixekizumab与guselkumab治疗中重度斑块状银屑病的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b012921503e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449603, encodeId=45d414496030d, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=NEJM：Tapinarof乳膏治疗斑块状银屑病的效果, objectType=article, longId=221806, objectId=f56c22180679, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f56c22180679, replyNumber=0, likeNumber=55, createdTime=2021-12-11, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f56c22180679, moduleTitle=NEJM：Tapinarof乳膏治疗斑块状银屑病的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f56c22180679)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449602, encodeId=37211449602d3, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=JAMA：乌司奴单抗停用后阿巴西普共刺激阻断对中重度斑块状银屑病患者的影响PAUSE 随机临床试验, objectType=article, longId=218928, objectId=8cc2218928d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8cc2218928d6, replyNumber=0, likeNumber=58, createdTime=2021-10-22, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8cc2218928d6, moduleTitle=JAMA：乌司奴单抗停用后阿巴西普共刺激阻断对中重度斑块状银屑病患者的影响PAUSE 随机临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8cc2218928d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449601, encodeId=efe4144960165, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=NEJM：Bimekizumab VS. Secukinumab 治疗斑块状银屑病的疗效及安全性, objectType=article, longId=218429, objectId=869b2184298f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=869b2184298f, replyNumber=0, likeNumber=49, createdTime=2021-10-13, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=869b2184298f, moduleTitle=NEJM：Bimekizumab VS. Secukinumab 治疗斑块状银屑病的疗效及安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=869b2184298f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449600, encodeId=50d11449600bb, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=BJD:瑞莎珠单抗vs司库奇尤单抗在中度至重度斑块状银屑病患者中的疗效和安全性, objectType=article, longId=216936, objectId=12a7216936f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=12a7216936f0, replyNumber=0, likeNumber=39, createdTime=2021-09-12, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=12a7216936f0, moduleTitle=BJD:瑞莎珠单抗vs司库奇尤单抗在中度至重度斑块状银屑病患者中的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=12a7216936f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449599, encodeId=97cd1449599b2, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=NEJM：Bimekizumab与阿达木单抗对斑块状银屑病的疗效比较，王者诞生？, objectType=article, longId=213912, objectId=0cae21391291, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0cae21391291, replyNumber=0, likeNumber=54, createdTime=2021-07-09, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0cae21391291, moduleTitle=NEJM：Bimekizumab与阿达木单抗对斑块状银屑病的疗效比较，王者诞生？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0cae21391291)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449598, encodeId=2a1814495986e, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=J Dermatol：布罗达单抗治疗斑块状银屑病伴/不伴银屑病关节炎具有长期疗效和安全性, objectType=article, longId=210780, objectId=a3b5210e804c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3b5210e804c, replyNumber=0, likeNumber=61, createdTime=2021-05-05, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3b5210e804c, moduleTitle=J Dermatol：布罗达单抗治疗斑块状银屑病伴/不伴银屑病关节炎具有长期疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3b5210e804c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449597, encodeId=194a144959ee0, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=J Invest Dermatol：PF-06700841对中重度斑块状银屑病患者普遍有效且耐受性良好, objectType=article, longId=210778, objectId=b052210e782f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b052210e782f, replyNumber=0, likeNumber=55, createdTime=2021-05-05, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b052210e782f, moduleTitle=J Invest Dermatol：PF-06700841对中重度斑块状银屑病患者普遍有效且耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b052210e782f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449596, encodeId=67e014495962f, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=UCB在《Lancet》上发表bimekizumab治疗斑块状银屑病的全新数据, objectType=article, longId=206929, objectId=119120692979, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=119120692979, replyNumber=0, likeNumber=69, createdTime=2021-02-10, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=119120692979, moduleTitle=UCB在《Lancet》上发表bimekizumab治疗斑块状银屑病的全新数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=119120692979)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1449595, encodeId=80d21449595b5, content=<a href='/topic/show?id=446f5e934a9' target=_blank style='color:#2F92EE;'>#斑块状银屑病#</a>, objectTitle=斑块状银屑病重大进展！西安杨森Tremfya(特诺雅，古塞奇尤单抗)获国家药监局(NMPA)批准上市！, objectType=article, longId=192695, objectId=249d19269580, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=249d19269580, replyNumber=0, likeNumber=55, createdTime=2020-04-23, rootId=0, userName=gous, userId=1ecb5492626, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=249d19269580, moduleTitle=斑块状银屑病重大进展！西安杨森Tremfya(特诺雅，古塞奇尤单抗)获国家药监局(NMPA)批准上市！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=249d19269580)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

斑块状银屑病

2020-05-29

循证小兵 (审核中...)

前往app查看评论内容

#米利珠单抗#可有效治疗中重度#斑块状银屑病#成年患者

Br J Dermatol：米利珠单抗可有效治疗中重度斑块状银屑病成年患者

2022-12-16发表于上海

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

J Eur Acad Dermatol Venereol：Brodalumab治疗中重度斑块状银屑病的长期疗效和安全性

2022-08-24

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

J Cosmet Dermatol：点阵二氧化碳激光辅助外用环孢素乳膏VS.外用氯倍他索乳膏治疗斑块状银屑病的疗效

2022-08-24

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

Dermaliq Therapeutics宣布在评估DLQ02治疗斑块状银屑病的1b/2期试验中向首例患者给药

2022-08-24

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

Dermatol Ther：阿普斯特单药治疗是中重度斑块状银屑病的有效治疗方案

2022-08-01

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

Br J Dermatol：在体重≥90 kg的中重度斑块状银屑病患者中Secukinumab 的疗效如何？

2022-07-23

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

两年研究数据证实：deucravacitinib治疗中重度斑块状银屑病兼具持久的疗效与一致的安全性

2022-05-14

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

JEADV：新型固定剂量钙泊三醇和二丙酸倍他米松乳膏可有效且安全的治疗斑块状银屑病

2022-04-06

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

J Dermatolog Treat：ixekizumab治疗严重斑块状银屑病患者的疗效和安全性

2022-02-22

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

BioDrugs：AVT02 VS. 原研药阿达木单抗在中重度慢性斑块状银屑病患者中的疗效、安全性和免疫原性

2022-01-09

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

Br J Dermatol：ixekizumab与guselkumab治疗中重度斑块状银屑病的疗效和安全性

2021-12-19

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

NEJM：Tapinarof乳膏治疗斑块状银屑病的效果

2021-12-11

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

JAMA：乌司奴单抗停用后阿巴西普共刺激阻断对中重度斑块状银屑病患者的影响PAUSE 随机临床试验

2021-10-22

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

NEJM：Bimekizumab VS. Secukinumab 治疗斑块状银屑病的疗效及安全性

2021-10-13

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

BJD:瑞莎珠单抗vs司库奇尤单抗在中度至重度斑块状银屑病患者中的疗效和安全性

2021-09-12

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

NEJM：Bimekizumab与阿达木单抗对斑块状银屑病的疗效比较，王者诞生？

2021-07-09

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

J Dermatol：布罗达单抗治疗斑块状银屑病伴/不伴银屑病关节炎具有长期疗效和安全性

2021-05-05

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

J Invest Dermatol：PF-06700841对中重度斑块状银屑病患者普遍有效且耐受性良好

2021-05-05

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

UCB在《Lancet》上发表bimekizumab治疗斑块状银屑病的全新数据

2021-02-10

gous (审核中...)

前往app查看评论内容

#斑块状银屑病#

斑块状银屑病重大进展！西安杨森Tremfya(特诺雅，古塞奇尤单抗)获国家药监局(NMPA)批准上市！

2020-04-23

科室
- - 订阅+
  - 更多科室
工具
服务